Main Capital Partners has acquired a majority stake in Polypoint, a Swiss specialist in digital workforce management for healthcare, to accelerate SaaS transformation and focus on AI-driven solutions.

Information on the Target

Polypoint is a leading Swiss company specializing in digital workforce management solutions tailored for the healthcare sector. Its platform offers hospitals, clinics, and care facilities the tools necessary to manage personnel deployment, track work hours, and allocate resources efficiently, transparently, and proactively. By utilizing intelligent algorithms for automated shift scheduling, real-time capacity management, and predictive resource allocation, Polypoint aims to reduce administrative burdens and enhance patient care delivery.

The healthcare industry faces significant challenges, particularly with a shortage of qualified staff and increasing operational demands. In many institutions, time is wasted on complex shift planning and resource coordination, adding to the strain on healthcare providers. Polypoint addresses these issues directly, allowing organizations to focus more on what truly matters: patient care.

Industry Overview in Switzerland

The healthcare industry in Switzerland operates under a highly regulated environment with a strong emphasis on quality and efficiency. As healthcare demands rise, driven by an aging

View Source

Similar Deals

Healthcare Holding Schweiz AG Sevika Medical AG

2025

Other Private Equity Advanced Medical Equipment & Technology (NEC) Switzerland
Galenica Diagnostics Group GmbH (Labor Team Gruppe inkl. labor team w ag)

2025

Other Private Equity Medical & Diagnostic Laboratories Switzerland
Ardian Dovida

2025

Other Private Equity Home Healthcare Services Switzerland
Healthcare Holding Schweiz AG Ino Medical Solutions GmbH

2025

Other Private Equity Medical Devices & Implants Switzerland
Healthcare Holding Schweiz AG MCM Medsys AG, Naropa Reha AG, MVB Medizintechnik AG

2024

Other Private Equity Hospitals, Clinics & Primary Care Services Switzerland
Gyrus Capital Essential Pharma

2024

Other Private Equity Proprietary & Advanced Pharmaceuticals Switzerland

Main Capital Partners

invested in

Polypoint

in 2025

in a Other Private Equity deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert